insights_auto
Why is RGEN down 2.99%?
Dive Deeperchevron_right
RGEN:NASDAQ
Repligen Corp
$162.78
arrow_downward
-2.99%(-5.01) 1D
$162.78
0.00% (0.00)
bedtimeAfter hours
Closed: Nov 16, 4:00:00 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for RGEN...
Open
$166.14
High
$166.79
Low
$162.48
Mkt. cap
10.41B
Avg. vol.
1.31M
Volume
565.30K
52-wk high
$198.86
52-wk low
$100.99
EPS
-$0.21
Beta
1.12
Shares outstanding
63.92M
No. of employees
2K
Open
$166.14
High
$166.79
Low
$162.48
Mkt. cap
10.41B
Avg. vol.
1.31M
Volume
565.30K
52-wk high
$198.86
52-wk low
$100.99
EPS
-$0.21
Beta
1.12
Shares outstanding
63.92M
No. of employees
2K
News stories
From web sources and news partners
ChartMill
·
1 hour ago
S&P 500 Top Movers: Gainers and Losers for Nov. 16, 2026
The Motley Fool
·
52 minutes ago
Here's How the S&P 500 Has Moved the Day After Each of Nvidia's Last 12 Reports
24/7 Wall St.
·
18 minutes ago
S&P 500 Closes Down 2% as Nasdaq Leads Broad Market Lower
cwibc.co.id
·
6 hours ago
Nasdaq and S&P 500 Fall Ahead of Nvidia Earnings
Profile
Repligen Corporation is an American life sciences company that develops and manufactures products used in biological drug manufacturing. The company is headquartered in Waltham, Massachusetts, and is listed on the Nasdaq under the symbol RGEN. Wikipedia
About Repligen Corp
CEOTony J. Hunt
Employees2K
Founded1981
HeadquartersWaltham, Massachusetts, United States
SectorHealth Care
Industry-
Websiterepligen.com